Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|MDA2013-02-02||CLO-MD Anderson||Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication of Barrett’s Esophagus with Radiofrequency Ablation||Cancer Prevention and Control CIRB||Available to Open|
|MDA2016-08-02||CLO-MD Anderson||A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer||Cancer Prevention and Control CIRB||Available to Open|
|MAY2016-07-01||CLO-Mayo Clinic||Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis||Cancer Prevention and Control CIRB||Available to Open|
|MAY2015-05-01||CLO-Mayo Clinic||Randomized, double-blind, placebo-controlled trial of Meriva® (curcuminoids) as a candidate chemoprevention agent for gastric carcinogenesis||Cancer Prevention and Control CIRB||Available to Open|
|MAY2016-08-01||CLO-Mayo Clinic||A Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer||Cancer Prevention and Control CIRB||Available to Open|
|MAY2017-09-01||CLO-Mayo Clinic||Phase I Double-Blind, Placebo-Controlled Trial of 27 mg Dolcanatide (SP-333) to Demonstrate Colorectal Bioactivity in Healthy Volunteers||Cancer Prevention and Control CIRB||Available to Open|
|S1505||SWOG||A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/NAB-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma||Adult CIRB - Late Phase Emphasis||Available to Open|
|S1616||SWOG||A Phase II Randomized Study of Nivolumab (NSC-748726) with Ipilimumab (NSC-732442) or Ipilimumab Alone in Advanced Melanoma Patients Refractory to an Anti-PD1 or Anti-PD-L1 Agent||Adult CIRB - Late Phase Emphasis||Available to Open|
|S0819||SWOG||A Randomized; Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)||Adult CIRB - Late Phase Emphasis||Available to Open|
|S0205||SWOG||A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (IMC-C225) Versus Gemcitabine as First-Line Therapy of Patients with Advanced Pancreas Cancer||Adult CIRB - Late Phase Emphasis||Completed|